en.aazsante.fr
Anvisa approves new drug to treat pancreatic cancer
The National Agency of Sanitary Surveillance (Anvisa) approved on Monday, April 10, a new drug to combat pancreatic cancer.
Abraxane (paclitaxel bound to albumin) is indicated for patients with metastatic pancreatic adenocarcinoma, a rare disease of aggressive behavior and a high mortality rate.
The authorization was for the lyophilized powder form for injectable suspension in the concentration of 100 mg. The drug will be manufactured by the company Abrais BioScience, of Phoenix, in the United States. In Brazil, Celgene Brasil Produtos Farmacêuticos Ltda., From Vargem Grande Paulista, in São Paulo, is the record holder.
Uterine fibroids rarely become cancer
Uterine fibroids are an absolutely common finding in the female population. They are benign tumors of the uterine body that usually originate between 25 and 40 years of age. This benign tumor accounts for about 50% of women in the 30 to 50 age group. The technical name is leiomyomas, benign smooth muscle tumors, which distinguish them from leiomyosarcomas, which are their malignant counterparts.
Ministry of Health declares end of outbreak of yellow fever in country
The Ministry of Health announced on Wednesday (06) the end of the outbreak of yellow fever in the country. Since June, when the last case in Espírito Santo was confirmed, Brazil has no records of the disease. According to the agency, the prevalence of the disease occurs in the hot months between December and April, and, with the end of this seasonality, the number of cases is expected to be reduced.
